IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)

Summary

The National Institutes of Health (NIH) is forecasting a funding opportunity for an IGVF (Impact of Genomic Variation on Function) Data and Coordinating Center under the U24 cooperative agreement mechanism. Clinical trials are explicitly not allowed. The center is expected to serve a data coordination and management function in support of the IGVF consortium. This is a forecasted opportunity, meaning full details have not yet been released.

What they want

Risks & flags

• Forecasted status only — full scope, eligibility, and evaluation criteria not yet published; limited intelligence available to assess competitiveness
• U24 cooperative agreement mechanism often favors established consortium participants with prior IGVF or NIH large-scale genomics infrastructure experience